VAXINE PTY LTD has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are HENDERSON MORLEY PLC, ONYVAX LTD and NORDIC VACCINE TECHNOLOGY AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Polysaccharides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Petrovsky Nikolai | 11 |
#2 | Cooper Peter D | 5 |
#3 | Nikolai Petrovsky | 1 |
#4 | Marion Vincent | 1 |
#5 | Cooper Peter | 1 |
#6 | Petrosky Nikolai | 1 |
Publication | Filing date | Title |
---|---|---|
BR112013032675A2 | adjuvant vaccine composition comprising inulin particles | |
WO2011032229A1 | A novel epsilon polymorphic form of inulin and compositions comprising same | |
WO2006024100A1 | New polymorphic form of inulin and uses thereof | |
AU2005279709A1 | New polymorphic form of inulin and uses thereof |